ACE and congestive heart failure: However, the very first clinical trial, the VALVE study, which compared double with triple therapy, i.e., adding an ACE inhibitor, ramipril, to pimobendan and furosemide treatment, did not show any beneficial effect on survival in dogs with CHF secondary to MMVD [18].